Dyssomnia in the structure of post-covid syndrome

126 patients were examined at out-patient department of Republican Research Center for Radiation Medicine and Human Ecology. Two groups were formed. The main group (48 people) are anxious patients with signs of coronaphobia and a suspicion of having the consequences of coronavirus infection (examined in the first half of 2022). The average age is 42 years. 28 people with post-COVID syndrome (examined in the first half of 2023). The average age is 49 years. The comparison group (50 people) — patients with neuropsychiatric disorders, observed by a psychotherapist in a counseling group, fell ill before the COVID-19 pandemic (examined in the first half of 2022). The average age is 48 years. All patients were examined by a psychotherapist and a general practitioner. The methodology of ecological psychiatry was used. The author’s quantified card was filled in, including the following sections: socio-demographic; perception of socio-environmental factors; anamnestic; clinical with verification according to ICD-10 criteria with the identification of the syndromic structure; psychometric assessment of anxiety according to the GAD-7 scale and vegetative support according to A.M. Wayne. All examined patents were divided according to the presence of dyssomnia and its absence. As a result of the study, the prevalence of dyssomnia in the main group was 63,5% and increased dynamically: 51% in the covid phobia subgroup, 88% in the post-COVID syndrome subgroup, and 4% in the comparison group. A complication of the structure of anxiety disorders with associated dyssomnia was defined at the early stage of the study (with a neurotic anxiety register) and at the late stage, in the subgroup with post-COVID syndrome, with a predominantly organic genesis. It follows the idea of a well-known independent role of dyssomnia, which aggravates the psychopathological register with an increase in depressive inclusions; organic transformation of neurosis-like disorders and symptoms of cognitive dysfunction. The increase in the incidence of cognitive dysfunction is consistent with a decrease in the perception of the coronavirus infection factor, especially in the subgroup with post-COVID syndrome. In the comparison group receiving psychopharmacotherapy, dyssomnia was practically absent. And according to all other studied indicators, the comparison group is lighter than the main group. Based on the study, approaches to psychopharmacotherapy of post-COVID syndrome, including dyssomnia, were identified.

1. Davis, H.E. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact / Davis H.E., Assaf G.S., McCorkell L., et al // EClinicalMedicine. – 2021. – №38.

2. Bard, H. Ariel. Insomnia, depression, and anxiety symptoms interact and individually impact functioning (UK): A network and relative importance analysis in the context of insomnia / H. Ariel Bard, Ciar an O'Driscoll, Christopher B. Miller, Alasdair L. Henry, John Cape, Colin A.// Sleep Med. – 2023. – Jan:101. – P.505-514.

3. Hailey, Meaklim. Insomnia is a key risk factor for persistent anxiety and depressive symptoms: A 12-month longitudinal cohort study during the COVID-19 pandemic / Hailey Meaklim, William J. Saunders, Michelle L. Byrne, Moira F. Junge, Prerna Varma, Wendy A. Finck, Melinda L. Jackson //J Affect Disord. – 2023. – Vol.1(322). – P.52-62.

4. Robert, N Glidevell. Insomnia and anxiety: Diagnostic and Management implications of complex interaction / Robert N Glidevell, E.Vc Pherson Botts, William C Orr.// Sleep Med Clin. – 2015. – Mar;10(1). – P.93-9.

5. Vorob'ev, P.A. Postkovidnyj sindrom: obraz bolezni, koncepciya patogeneza i klassifikaciya / Vorob'ev P.A., Vorob'ev A.P., Krasnova L.S. // Problemy standartizacii v zdravoohranenii. 2021. – №5-6. – S.3-10.

6. Bronskij, V.I. Postkovidnyj sindrom s pozicii ekologicheskoj psihiatrii / Bronskij V.I., Tolkanec S.V., Bronskaya K.V., Gavrilyuk E.N.// Mediko-biologicheskie problemy zhiznedeyatel'nosti. – 2024. – №1(31). – S.88-94.

7. Hajbullina, D.H. Astenicheskij postkovidnyj sindrom / Hajbullina D.H., Maksimov YU.N //ZHurnal nevrologii i psihiatrii im. S.S.Korsakova. – 2023. – T.123. – №3. – S.61-69.

8. Kruglyj stol «Vozmozhnosti terapii narushenij sna. Medicinskij vestnik. – 2024, 21 marta №12, s.12-14.

9. Mendelevich, V.D. Dissomnicheskie (insomnicheskie) rasstrojstva psihonevrologicheskaya dilemma v diagnostike i terapii // ZHurnal nevrologii i psihiatrii im. S.S.Korsakova. Specvypuski. – 2016. – T.116, №11-2. – S.18-23.

10. Oprosnik GTR-7 (GAD-7) i rekomendacii WFSBP po terapii generalizovannogo trevozhnogo rasstrojstva // Obozrenie psihiatrii i medicinskoj psihologii. – 2013. – №2. – S.78-85.

11. Vejn, A.M. Vegetativnaya distoniya / Vejn A.M., YAkovlev N.A., Slyusar' T.A. Moskva, 1996. – 373 s.